{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:02:13Z","timestamp":1759881733922,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.abd.2020.10.010","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T02:28:20Z","timestamp":1632968900000},"page":"782-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid"],"prefix":"10.1016","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8379-7427","authenticated-orcid":false,"given":"Agoritsa","family":"Gravani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8602-2216","authenticated-orcid":false,"given":"Panagiota","family":"Christou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-8983","authenticated-orcid":false,"given":"Stelios","family":"Tigas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0252-8314","authenticated-orcid":false,"given":"Ioannis D.","family":"Bassukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2020.10.010_bib0005","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1111\/jdv.14957","article-title":"Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors","volume":"32","author":"Gravani","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.abd.2020.10.010_bib0010","first-page":"921","article-title":"Statins in skin: research and rediscovery, from psoriasis to sclerosis","volume":"9","author":"Egesi","year":"2010","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.abd.2020.10.010_bib0015","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/bph.14140","article-title":"Prophylactic benefits of systemically delivered simvastatin treatment in a house dust mite challenged murine model of allergic asthma","volume":"175","author":"Jha","year":"2018","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.abd.2020.10.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107515","article-title":"The association of dipeptidyl peptidase IV inhibitors and other risk factors with bullous pemphigoid in patients with type 2 diabetes mellitus: A retrospective cohort study","volume":"34","author":"Guo","year":"2020","journal-title":"J Diabetes Complications."},{"key":"10.1016\/j.abd.2020.10.010_bib0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jid.2018.11.025","article-title":"Gliptin-associated bullous pemphigoid: A valuable model of the mechanism of breakdown of immune tolerance against BP180","volume":"139","author":"Nishie","year":"2019","journal-title":"J Invest Dermatol."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059621002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059621002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:40:30Z","timestamp":1759794030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059621002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0365059621002312"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2020.10.010","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"print","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Co-medications and dipeptidyl peptidase-4 inhibitors associated bullous pemphigoid","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2020.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}